UW News

Valerie Daggett


April 15, 2019

Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer’s disease, researchers show

a chemical structure of a peptide

A team led by researchers at the University of Washington has developed synthetic peptides that target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease.


July 28, 2014

New protein structure could help treat Alzheimer’s, related diseases

An abnormal protein, left, is intercepted by the UW’s compound that can bind to the toxic protein and neutralize it, as shown at right.

University of Washington bioengineers have a designed a peptide structure that can stop the harmful changes of the body’s normal proteins into a state that’s linked to widespread diseases such as Alzheimer’s, Parkinson’s, heart disease, Type 2 diabetes and Lou Gehrig’s disease.